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Aline C. Habison,a Chantal Beauchemin,a J. Pedro Simas,b Edward J. Usherwood,c and Kenneth M. Kayea
Channing Laboratory and Departments of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USAa; Instituto de
Microbiologia e Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugalb; and Department of Microbiology and Immunology,
Dartmouth Medical School, Lebanon, New Hampshire, USAc
Murine gammaherpesvirus 68 (MHV68) ORF73 (mLANA) has sequence homology to Kaposi’s sarcoma-associated herpesvirus
(KSHV) latency-associated nuclear antigen (LANA). LANA acts on the KSHV terminal repeat (TR) elements to mediate KSHV
episome maintenance. Disruption of mLANA expression severely reduces the ability of MHV68 to establish latent infection in
mice, consistent with the possibility that mLANA mediates episome persistence. Here we assess the roles of mLANA and MHV68
TR (mTR) elements in episome persistence. mTR-associated DNA persisted as an episome in latently MHV68-infected tumor
cells, demonstrating that the mTR elements can serve as a cis-acting element for MHV68 episome maintenance. In some cases,
both control vector and mTR-associated DNAs integrated into MHV68 episomal genomes. Therefore, we also assessed the roles
of mTRs as well as mLANA in the absence of infection. DNA containing both mLANA and mTRs in cis persisted as an episome in
murine A20 or MEF cells. In contrast, mTR DNA never persisted as an episome in the absence of mLANA. mLANA levels were
increased when mLANA was expressed from its native promoters, and episome maintenance was more efficient with higher
mLANA levels. Increased numbers of mTRs conferred more efficient episome maintenance, since DNA containing mLANA and
eight mTR elements persisted more efficiently in A20 cells than did DNA with mLANA and two or four mTRs. Similar to KSHV
LANA, mLANA broadly associated with mitotic chromosomes but relocalized to concentrated dots in the presence of episomes.
Therefore, mLANA acts on mTR elements to mediate MHV68 episome persistence.
Murine gammaherpesvirus 68 (MHV68 or murid herpesvirus4) is a gamma-2 herpesvirus that was isolated from a natu-
rally infected rodent, the bank vole (Clethrionomys glareolus) (7,
8). Similar to the case with other gamma-2 herpesviruses, follow-
ing viral replication at the primary site of inoculation, latent, per-
sistent MHV68 infection occurs. MHV68 predominantly latently
infects B cells, but latent infection also occurs in epithelial cells,
macrophages, and dendritic cells (22, 23, 46, 49, 59, 67). The es-
tablishment of latent infection in mice causes an infectious mono-
nucleosis-like syndrome with lymphocyte activation (20).
MHV68 is genetically similar to other gammaherpesviruses,
including the human Kaposi’s sarcoma-associated herpesvirus
(KSHV; also known as human herpesvirus 8 [HHV-8]) (a gamma-
2 herpesvirus) and Epstein-Barr virus (EBV) (a gamma-1 herpes-
virus), both of which are associated with human malignancies (26,
39, 53, 57). For example, the 118-kb unique sequence of
MHV68 features a GC content of 46% and contains1.2-kb ter-
minal repeat (TR) elements that are 78% GC rich, while the KSHV
genome contains an140-kb unique sequence with a GC content
of 54% and 0.8-kb TR elements that are 85% GC rich (54, 64).
Moreover, the80 open reading frames (ORFs) carried by the
MHV68 genome are largely colinear with those of the genomes
of KSHV, EBV, and other gammaherpesviruses, such as herpes-
virus saimiri (HVS), a New World monkey virus (1). MHV68
infection of mice is often used as a tractable small-animal
model for gammaherpesviruses and is particularly relevant for
KSHV (24, 56, 58).
During latency, the gammaherpesvirus genome persists as a
circularized, extrachromosomal episome (plasmid) (16, 17, 61).
Therefore, in order to persist in proliferating cells, the episomal
genomes must replicate and segregate to daughter nuclei. In la-
tently infected cells, only a limited subset of genes is expressed (46,
57). Among them, ORF73 is known to be responsible for viral
episome maintenance in at least two other gamma-2 herpesvi-
ruses, i.e., HVS and KSHV (3, 4, 10, 13, 63).
KSHV ORF73 encodes the latency-associated nuclear antigen
(LANA) (54) (Fig. 1A). LANA is a 1,162-amino-acid viral protein
that mediates KSHV episome persistence (3, 4). C-terminal LANA
binds specific sequence in the KSHV TR element to mediate its
replication, and this binding is essential for episome maintenance
(4, 15, 21, 27, 28, 32, 33, 41, 45). In addition, N- and C-terminal
LANA regions associate with mitotic chromosomes (5, 36, 37, 42,
44, 51, 69). N-terminal LANA attaches to mitotic chromosomes
through binding of core histones H2A and H2B (6). Through
simultaneous binding of KSHV DNA and chromosomes, LANA
tethers the viral episome to mitotic host chromosomes to ensure
efficient episome segregation to daughter nuclei during cellular
division. Therefore, KSHV LANA allows genome persistence by
mediating both viral DNA replication and segregation of epi-
somes to progeny nuclei.
MHV68 ORF73 (mLANA) is homologous to KSHV LANA,
particularly in the C-terminal domain (Fig. 1A). mLANA is com-
prised of 314 amino acids, which is considerably smaller than the
1,162-amino-acid KSHV LANA (64). Most of the difference in
size is due to the absence of internal acidic and glutamine-rich
repeat elements in mLANA. Recombinant MHV68 disrupted for
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FIG 1 Schematic diagrams. (A) Comparison of KSHV LANA and mLANA. Homologous regions are shown with similar shading. Unshaded regions lack
homology. The C-terminal domains (darkly shaded) share the highest level of homology. C-terminal KSHV LANA mediates self-association, DNA binding, and
chromosome association. N-terminal KSHV LANA (residues 1 to 32) mediates chromosome association through interaction with histones H2A and H2B and
includes a nuclear localization signal. Amino acid residues are indicated. P, proline-rich region; LZ, predicted leucine zipper. (B) Schematic diagram of mLANA
transcription from the MHV68 genome. MHV68 ORFs are indicated. The three potential LANA promoters, p1, p2, and p3, are indicated. Genomic nucleotide
positions are indicated for the terminal repeat, the mLANA ORF, and exons 1, 2, and 3 (2, 12). When expressed from an upstream mTR element, multiple exon
1 copies are present in transcripts. A second exon (not shown) in the mTR (located at positions 119,373 to 119,195) can be driven by promoter p2 from an
upstream mTR element, and a single copy of this exon is then spliced to exon 1 copies (12, 34). The line drawn above exon 3 and promoter 3 and extending into
ORF75c indicates the sequence upstream of mLANA included in the native promoter constructs used in this work. (C) Schematic diagrams of mLANA and mTR
constructs used in this work. Promoters are indicated. One arrow is used in the mTRs to represent the two potential promoters present in each of the mTRs (see
panel A and Discussion for details). Arrows within the mTR elements indicate the direction relative to mLANA. In the native genomic MHV68 orientation, the
arrow points toward mLANA. Summaries of numbers of G418-resistant cell lines positive for episomes over the total number tested, with percentages in
parentheses, are shown at right for A20 and MEF cells. ND, not determined.
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mLANA expression is highly compromised in the ability to estab-
lish efficient latent infection and persistence in mice (25, 48, 50).
These data are consistent with the possibility that mLANA may
mediate episome persistence of MHV68 DNA. In addition, since
LANA acts on the KSHV TRs to mediate episome persistence, it is
possible that mLANA may act on the MHV68 TR (mTR) elements
to mediate episome maintenance.
In this work, we evaluated whether mLANA acts on the mTR
elements to mediate episome persistence of MHV68 DNA. We
found that a plasmid containing mTR elements can persist as an
episome in an MHV68-infected mouse tumor cell line. Further-
more, plasmids containing mLANA and mTR elements in ciswere
capable of persisting as episomes in uninfected cells. These find-
ings indicate that mLANA acts on the MHV68 TR elements to
maintain viral episomes, analogous to the effect of LANA on the
KSHV TRs.
MATERIALS AND METHODS
Cell lines. A20 murine B lymphoma cells (40) were cultured in RPMI
medium supplemented with 10% Fetalplex (Gemini) or bovine growth
serum (BGS) (HyClone), beta mercaptoethanol, sodium pyruvate, Glu-
tamax (Invitrogen), and 15 g/ml gentamicin. Baby hamster kidney
(BHK) cells and mouse embryonic fibroblast (MEF) cells were main-
tained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% BGS, beta mercaptoethanol, and 15g/ml gentamicin. S11 cells
(61) were maintained in RPMI medium supplemented with 20% BGS
supplemented with beta mercaptoethanol.
Virus infection and purification. BHK21 cells at75% confluence in
five 500-cm2 cell culture dishes were infected with MHV68 at a multiplic-
ity of infection of 0.001 in DMEM containing 2% Fetalplex (12 ml/dish)
for 1 h at 37°C. Fifty milliliters of DMEM containing 10% Fetalplex was
then added, and cells were incubated for 3 days, at which time plaques
were evident. Cells were trypsinized, collected by centrifugation, and in-
cubated in 1.5 ml RSB buffer (10 mM Tris-HCl, pH 7.5, 10 mM KCl, 1.5
mM MgCl2) per plate, supplemented with 0.5% NP-40, for 10 min at 4°C.
Centrifugation was then performed to remove nuclei, and the supernatant
was collected. Centrifugation of the supernatant in microcentrifuge tubes
was performed at 20,800 g for 2 h at 4°C. Pellets containing virus were
resuspended in 400 l NTE buffer (100 mM NaCl, 10 mM Tris-HCl, pH
7.5, 1 mM EDTA) by sonication. SDS and additional EDTA were then
added to final concentrations of 2.5% SDS and 10 mM EDTA, and incu-
bation was performed for 5 min at 37°C. Virus DNA was purified using
DNAzol (Invitrogen) according to the manufacturer’s instructions.
Plasmids. MHV-68 TR (mTR) elements were cloned from purified
MHV68 DNA. First, virus DNA was digested with Tsp509I, which digests
frequently in the unique sequence but not in the mTRs. Subsequently,
partial NotI digestion was performed. mTR elements each have one NotI
site. Fragments containing two, four, and eight TR copies were gel purified
and ligated into the NotI site of the pRepCK vector (4) to generate m2TR,
m4TR, and m8TR, respectively (Fig. 1C).
Plasmids expressing mLANA from a cytomegalovirus (CMV) pro-
moter were constructed. Linker NS contains NsiI and StuI sites and was
generated by annealing the sequences NSfwd (TC GAG ATG CAT GCT
CGA TAC AGC AGG CCT AAG G) and NSrev (GA TCC CTT AGG CCT
GCT GTA TCG AGC ATG CAT C). Linker NS was then inserted into
pRepCK, m2TR, m4TR, and m8TR, after digestion of each with XhoI and
BamHI, to generate pRepCK-NS, m2TR-NS, m4TR-NS, and m8TR-NS,
respectively. To generate pCMVFmLANA, mLANA was amplified from
MHV68 DNA by using the primers mLANAfwd (CGC GGA TCC ATG
CCC ACA TCC CCA CCG) and mLANArev1 (TCG ATA TCT TAT GTC
TGA GAC CCT TGT CC), which add a BamHI site upstream of mLANA
and an EcoRV site immediately downstream of mLANA. The PCR prod-
uct was digested with BamHI and EcoRV and inserted into the BamHI and
EcoRV sites of pCMV-3Tag-6 (Stratagene), resulting in pCMVFmLANA,
which contains a 3 FLAG tag upstream of mORF73. The 3 FLAG tag
was then removed by digestion with BamHI and NotI, and the sites were
blunted and ligated, resulting in pCMVmLANA. pCMVmLANA was di-
gested with NsiI and PsiI, releasing the CMVmLANA expression cassette,
and this was inserted into the NsiI and StuI sites of pRepCK vector-NS,
m2TR-NS, and m4TR-NS to generate CmLANA, CmLANA-m2TR, and
CmLANA-m4TR, respectively. These constructs contain mLANA with-
out an epitope tag driven by the CMV promoter and containing 0, 2, or 4
mTRs.
Constructs containing 3 C-terminal FLAG-tagged mLANA driven
by a CMV promoter were generated. pCMVmLANAF was constructed in
the same fashion as pCMVFmLANA, except that the PCR amplification of
mLANA was performed with primers mLANAfwd and mLANArev2
(TCG ATA TCT GTC TGA GAC CCT TGT CC). mLANArev2 omits the
native mLANA stop codon and contains an EcoRV site at its 5= end. The
N-terminal 3 FLAG tag was removed with BamHI and NotI as described
above. The 3 FLAG tag was PCR amplified from pCMV-3Tag-6 with
oligonucleotides FLAG fwd (CGG ATA TCG CGG TGG CGG CCG CC)
and FLAG rev (CCG GCT CGA GTT AGA ATT CCT GCA GCC CGG G),
which add a stop codon immediately downstream of the 3 FLAG tag and
EcoRV and XhoI sites at the 5= and 3= ends, respectively. The PCR product
was digested with EcoRV and XhoI and inserted into the EcoRV and XhoI
sites (of the vector polylinker) in pCMVmLANA, lacking the native stop
codon, to generate pCMVmLANAF, which contains a C-terminal 3
FLAG epitope-tagged mLANA sequence driven by the CMV promoter.
The CMV mLANA FLAG expression cassette was released by digestion
with NsiI and PsiI and inserted into the NsiI and StuI sites of pRepCK-
NS, m2TR-NS, m4TR-NS, and m8TR-NS to generate CmLANAF,
CmLANAF-m2TR, CmLANAF-m4TR, and CmLANAF-m8TRrev, re-
spectively (Fig. 1C).
Plasmids containing mLANA driven from its native promoter were
generated. Oligonucleotides m73fwd and m73rev were used to amplify
the mLANA sequence, including 2,037 bp upstream of the mLANA open
reading frame, from MHV68 DNA.
Oligonucleotide m73fwd (CAGCTCGAGATCCAGACTTTGGAGCA
TATGTTT) contains an XhoI site at the 5= end, and oligonucleotide
m73rev (CGCGGATCCTTATGTCTGAGACCCTTGTCC) contains a
BamHI site at its 5= end. The PCR product was digested with XhoI and
BamHI, gel purified, and inserted into XhoI- and BamHI-digested
pRepCK, m2TR, m4TR, and m8TR to generate mLANA, mLANA-m2TR,
mLANA-m4TR, and mLANA-m8TRrev, respectively (Fig. 1C). To gen-
erate mLANA-m8TR, mLANA-2TR (Fig. 1C) was digested with NheI and
XhoI to remove the mTR elements, and a linker containing the XhoI, NsiI,
SacI, StuI, and NheI restriction sites was generated by annealing oligonu-
cleotides NXfwd (CTAGGCTCGAGATGCATGAGCTCAGGCCTGCTA
GCG) and NXrev (TCGACGCTAGCAGGCCTGAGCTCATGCATCTC
GAGC) and inserted into the NheI and XhoI sites. The linker construction
destroyed the original NheI and XhoI sites in the parent plasmid, and the
inserted sites resulted in reversing the orientation of XhoI and NheI com-
pared to the original vector. m8TR was digested with XhoI and NheI,
removing the 8 mTR units, and these were inserted into the XhoI and
NheI sites of the plasmid containing the linker to generate mLANA-
m8TR, which contains the 8 mTR units in opposite orientation compared
with mLANA-m8TRrev and results in the native genomic orientation of
the mTRs relative to mLANA.
C-terminal mLANA FLAG epitope tags were inserted into constructs
expressing mLANA from its native promoter. pCMVmLANAF (described
above) was digested with PciI and PsiI, releasing a C-terminal portion of
the mLANAF expression cassette, and this fragment was inserted into
PciI- and HpaI-digested mLANA, mLANA-m2TR, mLANA-m4TR,
mLANA-m8TRrev, and mLANA-m8TR to generate mLANAF,
mLANAF-m2TR, mLANAF-m4TR, mLANAF-m8TRrev, and mLANAF-
m8TR, respectively (Fig. 1C). All PCR-amplified coding sequences were
confirmed by sequencing. Clones were expanded in Stbl2 (Invitrogen)
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bacteria for large-scale DNA preparations due to the greater stability of
the repeat elements in these bacteria.
Episome maintenance assays. S11 cells were maintained in log-phase
growth by reseeding at 0.2  106 cells/ml for three consecutive days. A
total of 10  106 cells were transfected by electroporation with 35 g of
m4TR, m8TR, or vector (pRepCK) in 400 l, using a BTX Electrosquare
Porator T820 electroporation system, pulsing the cells once at 200 V for 65
milliseconds. Immediately after transfection, cells were supplemented
with 0.5 ml of medium in the cuvette and incubated at room temperature
for 10 min. Cells were then transferred to T25 flasks in 5 ml medium. At 3
days posttransfection, cells were seeded at 10,000 or 1,000 cells per well in
96-well plates in medium containing G418 (400 g/ml) (Gemini). G418-
resistant cells were then expanded in preparation for detection of epi-
somes.
A20 cells were kept in log-phase growth by reseeding at 0.3  106
cells/ml for three consecutive days. A total of 10  106 A20 cells were
transfected with 35 g vector (pRepCK), mLANA, CmLANA, mLANAF,
CmLANAF, m2TR, m4TR, m8TR, m73-m2TR, mLANA-m4TR,
mLANA-m8TR, mLANA-m8TRrev, mLANAF-m2TR, mLANAF-m4TR,
mLANAF-m8TR, mLANAF-m8TRrev, CmLANA-m2TR, CmLANA-
m4TR, CmLANAF-m2TR, CmLANAF-m4TR, or CmLANAF-m8TRrev
in 400 l by electroporation using a BTX Electrosquare Porator T820
electroporation system, pulsing the cells once at 225 or 250 V for 65 mil-
liseconds. After transfection, cells were treated similarly to S11 cells, ex-
cept that at 72 h posttransfection cells were seeded at 1,000, 100, or 10 cells
per well in medium containing G418 (400 g/ml) (Gemini) and G418-
resistant cells expanded.
MEF cells were transfected with 2 g of mLANA, m8TR, mLANA-
m8TRrev, mLANA-m2TR, mLANA-m4TR, or mLANAF-m4TR in 6-cm
dishes at about 75% confluence, using Effectene transfection reagent
(Qiagen) according to the manufacturer’s instructions. Two days after
transfection, cells were trypsinized, counted, and seeded at 10,000 or
50,000 cells in a 15-cm dish. The next day, cells were rinsed with phos-
phate-buffered saline, and fresh medium containing G418 (1,000 g/ml)
(Gemini) was added. G418-resistant clones were picked and transferred
to 12-well plates for expansion.
Gardella analysis (29) was performed on G418-resistant clones. Cells
were loaded into gel wells composed of agarose containing DNase-free
protease (Sigma) and sodium dodecyl sulfate. In situ lysis of cells occurs as
electrophoresis begins in Tris-borate-EDTA buffer. DNA was then trans-
ferred to a nylon membrane and detected with a 32P-labeled probe. Probes
were DpnI digested prior to radiolabeling, except for the mLANA probe,
which was a PCR product amplified using the mLANAfwd and
mLANArev1 oligonucleotide primers and was not digested prior to radio-
labeling.
Western blots. A20 cells were transfected as described above. Extract
from 0.25 106 cells was loaded into each lane. Proteins were resolved by
SDS-PAGE in 8% polyacrylamide gels, transferred to nitrocellulose, and
detected with anti-FLAG antibody conjugated to horseradish peroxidase
(HRP) (Sigma), used at a 1:750 dilution, or mouse anti-tubulin monoclo-
nal antibody B-5-1-2 (Sigma), used at a 1:1,000 dilution. Incubation with
secondary anti-mouse HRP-conjugated antibody followed by chemilu-
minescence was performed to detect anti-tubulin antibody.
Fluorescence microscopy. For metaphase spreads, MEF cells were
grown in six-well dishes to 80% confluence and then incubated overnight
in 1 g/ml of colcemid (Calbiochem) to induce metaphase arrest. Colce-
mid-treated cells were swollen in hypotonic buffer for 20 min (1% sodium
citrate, 10 mM CaCl2, 10 mM MgCl2), spread onto slides by the cytospin
method (Thermoshandon), fixed for 10 min in 4% paraformaldehyde
(Polysciences) in phosphate-buffered saline, and permeabilized for 5 min
in 0.5% Triton X-100 in phosphate-buffered saline. To detect FLAG
epitope-tagged mLANA, cell spreads were incubated with M2 anti-FLAG
monoclonal antibody (Sigma) at a 1:750 dilution. Secondary anti-mouse–
Alexa Fluor 488 (Molecular Probes) was used to detect M2. Cells were
counterstained with propidium iodide (Molecular Probes) (1 g/ml) to
detect DNA, and coverslips were applied with Aqua-Poly mounting re-
agent (Polysciences). Microscopy was performed with a Zeiss Axioskop
microscope, PCM2000 hardware, and C-imaging software (Compix,
Inc.).
RESULTS
The MHV68 TR elements act in cis to mediate episome persis-
tence. Since the TR elements are the cis-acting sequence for KSHV
episome maintenance, we assessed whether the mTR elements are
the cis-acting element for MHV68. KSHV LANA acts on the
KSHV TR elements to mediate episome persistence. mLANA is
homologous to LANA (Fig. 1A) and is critical for establishment of
viral latency in mice. We hypothesized that the mTR elements
might have a role in episome maintenance similar to that of the
KSHV TRs.
We assayed whether MHV68 TR DNA can mediate extrachro-
mosomal persistence of DNA in murine B lymphoma S11 cells.
Most S11 cells are latently infected with MHV68, although some
S11 cells contain virus undergoing lytic replication. In latently
infected cells, MHV68 persists as a multicopy episome (61).
Therefore, the necessary factors responsible for MHV68 episome
persistence are expressed in these cells. If the mTRs are the cis-
acting sequence for episome persistence, then DNA containing
the mTR sequence is expected to be capable of persisting as an
episome in S11 cells. m8TR (contains eight copies of the MHV68
TR element), m4TR (contains four copies of mTR), or vector
alone was transfected into S11 cells. Cells were then seeded into
microtiter plates at 10,000 or 1,000 cells per well and placed under
G418 selection, for which resistance is encoded on the plasmid. In
at least three experiments, outgrowth of G418-resistant cells
transfected with m8TR was robust and occurred in all 96 wells in
the plates seeded with 10,000 cells per well and in an average of 20
wells in the plates seeded with 1,000 cells per well. Outgrowth was
also robust in cells transfected with m4TR, and an average of 86
wells were positive for outgrowth at 10,000 cells per well and 7
wells were positive at 1,000 cells per well. In contrast, after trans-
fection with the vector control, which lacks mTR elements, out-
growth occurred in only an average of 9 wells and 1 well after
seeding at 10,000 and 1,000 cells per well, respectively. These out-
growth data indicate that mTR DNA persists more efficiently than
the vector in S11 cells. The observed enhanced persistence could
be due to maintenance of mTR DNA as episomes or to increased
efficiency of integration of mTR DNA.
To assess the presence of m8TR episomal DNA, Gardella gel
analyses were performed on G418-resistant cell lines. In Gardella
gels (29), live cells are loaded into gel wells and lysed immediately
at the start of the gel run. Episomes as large as several hundred
kilobases can migrate into the gel, while chromosomal DNA re-
mains at the gel origin. Episomes are then detected by Southern
blotting. S11 cells (Fig. 2A, lanes 1, 11, and 20) contain episomes
but were not detected because the probe consisted of vector only,
which does not share sequence with MHV68. After 90 days of
G418 selection, m8TR episomes were detected in 11 (Fig. 2A, lanes
4, 6 to 10, 14, 15, and 17 to 19) of 16 lanes. In a total of two
experiments, 26 of 35 G418-resistant cell lines contained epi-
somes. In addition, three of six m4TR-transfected, G418-resistant
cell lines had episomes (data not shown). The episomes generally
migrated much slower than covalently closed circular plasmid
DNA (Fig. 2A, lane 2, faster-migrating band), consistent with re-
combination events. Selection of enlarged KSHV episomes is fre-
Habison et al.
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quently observed in KSHV episome maintenance assays and is due
to recombination events resulting in increased numbers of TR
elements in episomes. Therefore, MHV68 TR DNA can persist as
episomes in cells latently infected with MHV68.
Integration of transfected DNA into MHV68. Unexpectedly,
one of the two G418-resistant cell lines transfected with vector,
which lacks TR sequence, had large amounts of extrachromo-
somal DNA (Fig. 2A, lane 22). In fact, extrachromosomal signals
in vector-transfected S11 cells were observed for 3 of 6 G418-
resistant cell lines tested in a total of two experiments. Since the
vector lacks mTR DNA and any MHV68 sequence, it was expected
that integration into host cell chromosomes would be required to
allow persistence of DNA and that transfected DNA would not
persist as an episome. Notably, two of the G418-resistant cell lines
containing m8TR episomes (Fig. 2A, lanes 8 and 10) also had large
amounts of extrachromosomal DNA, which ran in a similar pat-
tern on the gel compared with that of the vector-transfected cell
line (Fig. 2A, lane 22). Of the 35 G418-resistant cell lines trans-
fected with m8TR, this finding of large amounts of extrachromo-
somal DNA was observed in 5 cell lines and in 1 of 6 G418-resis-
tant cell lines transfected with m4TR (Fig. 2 and data not shown).
One possible explanation for the vector being maintained as an
episome was that the vector had integrated into MHV68 genomes,
which are episomal. To test this possibility, the Southern blot was
stripped of signal and reprobed for a sequence present in MHV68
but not the transfected mTR DNA. Strikingly, overlay of the two
films demonstrated complete signal overlap for the cell line con-
taining extrachromosomal vector (data not shown). Notably, the
two cell lines containing m8TR DNA in a pattern similar to that of
the extrachromosomal vector noted above also had a confluence
of signals when the films were overlaid (data not shown). These
results are consistent with integration of vector and m8TR DNAs
into MHV68 genomes in these G418-resistant cell lines.
Since the integration of vector lacking any MHV68 DNA into
MHV68 episomal genomes was an unexpected event, we further
investigated this finding. S11 cells or a G418-resistant S11 cell line
transfected with vector (lacking mTR DNA) but containing ext-
rachromosomal vector DNA was assessed after 250 days of G418
selection. Cells were treated with 20 ng/ml tetradecanoyl phorbol
acetate (TPA) or 100 M acyclovir for 48 h. TPA induces lytic
infection, while acyclovir inhibits lytic infection. As expected,
probing with vector did not detect a signal in S11 cells (Fig. 2B,
lanes 1 to 3), since the probe lacks MHV68 sequence. However,
the vector probe detected episomal (E) (Fig. 2B, lane 4) and linear
(L) (Fig. 2B, lane 4) DNA (from lytic infection) in the G418-
resistant cells containing vector episomal DNA. Incubation with
TPA increased the vector-containing linear, replicating DNA sig-
nal (Fig. 2B, lane 5) but not the episomal signal, which is the
expected effect on S11 virus, since TPA induces lytic replication.
In contrast, treatment with acyclovir decreased the amount of
linear, replicating DNA but not the episomal signal (Fig. 2B, lane
6), which is the expected effect on MHV68 infection. A Gardella
gel with the same cell lines was also probed with mLANA, which is
present in MHV68 but not in the vector, to detect MHV68 DNA.
In both S11 cells and G418-resistant, vector-transfected S11 cells,
similar patterns of increasing linear DNA after TPA treatment and
decreased linear DNA after acyclovir treatment were observed
(Fig. 2B, lanes 13 to 18).
Simultaneous probing of a Gardella gel with sequences specific
for both vector and mTRs detected the same episomal and linear
FIG 2 mTR DNA persists as an episome in S11 cells. m8TR or pRepCK vector
was transfected into MHV68-infected S11 cells. Seventy-two hours later, cells
were seeded into microtiter plates at 10,000 cells/well or 1,000 cells/well and
placed under G418 selection. G418-resistant cells were expanded and assessed
for episomes by use of Gardella gels. This figure is representative of two exper-
iments. (A) Gardella gel containing S11 cells (lanes 1, 11, and 20), naked m8TR
(lane 2) or pRepCK (lane 3) plasmid DNA, m8TR-transfected, G418-resistant
S11 cells (lanes 4 to 10 and 12 to 19), and vector-transfected, G418-resistant
S11 cells (lanes 21 and 22). A total of1.5 106 cells was loaded in each lane.
G418-resistant cell lines were taken from plates seeded with 10,000 cells per
well (lanes 17 to 19, 21, and 22) or 1,000 cells per well (lanes 4 to 10 and 12 to
16). The Gardella gel analysis was performed after 90 days of G418 selection.
The faster-migrating signal for m8TR (lane 2) or vector (lane 3) is circular
covalently closed DNA. The blot was probed with 32P-radiolabeled pRepCK
vector DNA. (B) S11 cells (lanes 1 to 3, 7 to 9, and 13 to 15) and a vector-
transfected, G418-resistant S11 cell line (lanes 4 to 6, 10 to 12, and 16 to 18)
that contained episomal DNA were assessed after treatment with TPA or acy-
clovir (ACV). The experiment was performed after 250 days of G418 selection.
Probes consisted of vector (lanes 1 to 6), m8TR plasmid (which includes both
mTR and vector sequences) (lanes 7 to 12), and the mLANA ORF (lanes 13 to
18). For lanes 1 to 6, 1.5  106 cells were loaded per lane; for lanes 7 to 12,
0.15 106 cells were loaded per lane; and for lanes 13 to 18, 1.5 106 cells were
loaded per lane. Fewer cells were used with the mTR probe due to the greater
sensitivity of detection resulting from the number of repeated mTR elements
in MHV68. The gel origin (O) and S11 episomal (E) and linear (L) forms (due
to MHV68 lytic replication) are indicated.
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replicating DNA patterns with TPA and acyclovir. No additional
bands or doublets were detected in the cells containing episomal
vector DNA compared with the S11 cells (Fig. 2B, lanes 7 to 12).
This finding strongly indicates that both probes detected the same
bands. Overall, these findings are consistent with vector integra-
tion into MHV68 episomal genomes in some G418-resistant S11
cell lines. Furthermore, these results suggest that some G418-re-
sistant m8TR cell lines (such as in Fig. 2A, lanes 8 and 10) also have
integration of transfected vector into episomal MHV68 genomes.
Importantly, however, most G418-resistant cell lines transfected
with m8TR did not have an overlap of signal when probed for
mLANA compared with the vector probe. This result is therefore
consistent with independent episome persistence of the trans-
fected m8TR DNA in these lines.
CMV promoter-driven mLANA acts on mTR DNA in cis to
mediate low levels of episome persistence. Since m8TR and
m4TR persisted as episomes in S11 cells, we wished to investigate
whether mLANA acts on mTR DNA to mediate episome mainte-
nance analogous to the KSHV LANA function. To test this possi-
bility, we constructed plasmids containing CMV promoter-driven
mLANA or mLANA with a C-terminal FLAG tag (mLANAF), and
also plasmids containing two, four, or eight mTR elements
(termed CmLANA-m2TR, CmLANAF-m2TR, CmLANA-m4TR,
CmLANAF-m4TR, or CmLANAF-m8TRrev). As controls, we gen-
erated plasmids containing only mLANA (termed CmLANA or
CmLANAF) or used m2TR, m4TR, and m8TR, which contain only
TR elements. Uninfected mouse A20 B lymphoma cells were
transfected with m2TR, m4TR, m8TR, CmLANA, CmLANAF,
CmLANA-m2TR, CmLANAF-m2TR, CmLANA-4TR, CmLANAF-
4TR, or CmLANAF-m8TRrev. Cells were seeded into microtiter
plates at 3 days posttransfection and placed under G418 selection,
against which resistance is encoded by the plasmid vector. G418-
resistant cell outgrowth was similar for each of the transfections con-
taining mTR DNA, whether or not mLANA was present in cis. After
transfection with mTR-containing DNA, nearly all 96 wells were
positive for outgrowth in plates seeded at 1,000 cells/well,10 to
30 wells were positive after seeding at 100 cells per well, and0 to
5 wells were positive after seeding at 10 cells per well. G418-resis-
tant cell outgrowth for the CmLANA or CmLANAF transfections
was lower, at 50 positive wells for plates seeded at 1,000 cells/
well,10 positive wells after seeding at 100 cells per well, and0
to 2 wells after seeding at 10 cells per well. The comparable rates of
G418-resistant cell outgrowth with mTR transfections, regardless
of the presence of mLANA, were consistent with either an absence
of mLANA episome maintenance or episome maintenance occur-
ring at a rate similar to that of integration.
G418-resistant cells were expanded and assessed by Gardella
gel analysis for the presence of episomes. m2TR-transfected cells
(Fig. 3B, lanes 10 to 13), m4TR-transfected cells (Fig. 3A, lanes 5
and 6), and m8TR-transfected cells (Fig. 3B, lanes 31 to 34), which
contain mTR elements but not the mLANA sequence, did not
contain episomes. Similarly, cells transfected with CmLANA (Fig.
3A, lanes 21 to 24 and 33) or CmLANAF (Fig. 3B, lanes 19 to 22),
which contain the mLANA sequence but do not have mTR ele-
ments, also did not contain any episomes. Therefore, no episomes
were present when either mLANA was present without mTR ele-
ments or mTR elements were present without mLANA.
G418-resistant cells transfected with DNA containing both
mLANA and mTRs were also assessed for the presence of epi-
somes. CmLANAF-m2TR, which contains FLAG-tagged mLANA
and two mTRs, had no episomes in six G418-resistant cell
lines (Fig. 3B, lanes 13 to 18). Similarly, cells transfected with
CmLANA-m2TR, which contains mLANA without an epitope tag
and two mTRs, had no episomes in four G418-resistant cell lines
(data not shown). However, CmLANA-m4TR, which contains
mLANA and four mTR elements (Fig. 3A, lanes 7 to 20 and 27 to
32), had episomal DNA in four lanes (Fig. 3A, lanes 9, 27, 28, and
30), and in a total of two experiments, CmLANA-m4TR-trans-
fected cells had episomes in 9 of 33 (27%) G418-resistant cell lines.
In addition, CmLANAF-m4TR, which contains FLAG-tagged
mLANA and four mTR elements, had episomal DNA in one lane
(Fig. 3B, lane 5), and in a total of two experiments, CmLANAF-
m4TR had episomes in 2 of 24 (8%) G418-resistant cell lines.
CmLANAF-m8TRrev had episomes in 1 (Fig. 3B, lane 29) of 18
(6%) G418-resistant cell lines (Fig. 3B, lanes 25 to 30, and data not
shown). Therefore, when mLANA expressed from a CMV pro-
moter was present in cis with 4 or 8 mTR elements, episomes were
present in a small percentage of G418-resistant cell lines. This
finding is consistent with mLANA acting on mTR elements to
mediate low-efficiency episome persistence.
The native mLANA promoter drives higher-level mLANA
expression than the CMV promoter. We reasoned that a low ex-
pression level of mLANA might have been responsible for the low
efficiency of episome persistence and therefore assessed mLANA
expression levels driven by either the CMV promoter or the native
mLANA promoter. CmLANAF, CmLANAF-m2TR, CmLANAF-
m4TR, and CmLANAF-m8TRrev, which have mLANA driven by
the CMV promoter, were transfected into A20 cells and analyzed
for mLANA expression by immunoblotting with anti-FLAG anti-
body. CmLANAF-m4TR (Fig. 4, lanes 3 and 14) expressed
mLANA at a higher level than did CmLANAF (Fig. 4, lane 5) or
CmLANAF-m2TR (Fig. 4, lane 4). CmLANAF-m4TR mLANA
expression (Fig. 4, lanes 3 and 14) was also higher than that of
CmLANAF-m8TRrev (Fig. 4, lane 15). It is possible that the
higher expression level from CmLANAF-m4TR accounted for its
higher efficiency of episome persistence than that of CmLANAF-
m2TR or CmLANAF-m8TRrev (Fig. 3).
mLANAF, mLANAF-m2TR, mLANAF-m4TR, and mLANAF-
m8TRrev each have mLANA driven by its native promoter se-
quence and were also tested for mLANA expression levels. Three
native promoters have been described for mLANA, including one
immediately upstream of mLANA and two within the mTR ele-
ments (2, 12). The orientation of the mTR elements in relation to
mLANA in mLANAF-m2TR and mLANAF-m4TR is the same as
in genomic MHV68, but it is reversed in mLANAF-m8TRrev.
mLANAF (Fig. 4, lane 10) expressed mLANA at a similar level to
those of mLANAF-m8TRrev (Fig. 4, lane 7) and CmLANAF (Fig.
4, lane 5). mLANAF-m2TR (Fig. 4, lane 9) and mLANAF-m4TR
(Fig. 4, lane 8) expressed mLANA at substantially higher levels
than those of mLANAF and mLANAF-m8TRrev. The expression
level for mLANAF-m4TR was higher than that for mLANAF-
m2TR, as evident in the 10-s exposure (Fig. 4, middle panel, lanes
8 and 9, respectively). Therefore, the presence of upstream mTR
elements in the native genomic orientation relative to mLANA
substantially enhances mLANA expression, and the level of ex-
pression is much greater than that driven by the CMV promoter.
Furthermore, four upstream mTR elements were more efficient
than two mTR elements in driving mLANA expression.
Native promoter-driven mLANA maintains mTR episomes
with enhanced efficiency. Since higher mLANA expression oc-
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FIG 3 CMV promoter-driven mLANA in ciswith mTR elements persists in episomal form at low efficiency. A20 cells were transfected with plasmids containing
CMV promoter-driven mLANA and mTR elements or with mTR DNA. Seventy-two hours later, cells were seeded in microtiter plates at 1,000, 100, or 10
cells/well and placed under G418 selection. A total of 2 106 to 3 106 A20 cells was loaded per lane in Gardella gels, and 1.5 105 S11 cells were loaded per
lane. (A) Gardella gel containing S11 cells (lane 1), naked m4TR DNA (lane 2), naked CmLANA DNA (lanes 3 and 26), naked CmLANA-m4TR plasmid DNA
(lanes 4 and 25), m4TR-transfected, G418-resistant A20 cells (lanes 5 and 6), CmLANA-m4TR-transfected, G418-resistant A20 cells (lanes 7 to 20 and 27 to 32),
and CmLANA-transfected, G418-resistant A20 cells (lanes 21 to 24 and 33). G418-resistant cell lines were taken from plates seeded with 1,000 cells per well (lanes
22 and 24) or 100 cells per well (lanes 5 to 21, 23, 27 to 33). (B) Gardella gel containing naked CmLANA-m4TR (lane 1), naked m2TR (lane 2), naked
CmLANAF-m2TR (lane 3), naked CmLANAF (lane 4), naked CmLANAF-m8TR (lane 23), and naked m8TR (lane 24) plasmid DNA, as well as G418-resistant
A20 cells transfected with CmLANAF-m4TR (lanes 5 to 8), m2TR (lanes 9 to 12), CmLANAF-m2TR (lanes 13 to 18), CmLANAF (lanes 19 to 22), CmLANAF-
8TRrev (lanes 25 to 30), or m8TR (lanes 31 to 34). G418-resistant cell lines were taken from plates seeded with 100 cells per well (lanes 5 to 8, 10 to 12, 15 to 18,
20 to 22, and 30 to 34) or 10 cells per well (lanes 9, 13, 14, 19, and 25 to 29). The gel origin (O) is indicated. The number of days of G418 selection is shown below
each panel. For naked plasmid DNA, the fastest-migrating signal is circular covalently closed DNA. Blots were probed with 32P-radiolabeled m8TR DNA. Vertical
lines indicate migration locations of episomal DNA.
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curs from the native promoter than from the CMV promoter, we
assessed whether episome maintenance is enhanced when native
promoter-driven mLANA is oriented in cis with mTR elements.
mLANAF, m4TR, and mLANAF-m4TR were each transfected
into A20 cells, seeded into microtiter plates at a density of 1,000
cells per well, 100 cells per well, or 10 cells per well, and placed
under G418 selection. For m4TR and mLANAF-4TR, G418-resis-
tant outgrowth occurred in nearly all wells seeded at 1,000 cells per
well, in15 wells seeded at 100 cells/well, and in2 wells seeded
at 10 cells/well. This pattern of similar G418-resistant cell out-
growth after transfection of all mTR-containing DNA constructs
in both the presence and absence of mLANA continued in subse-
quent experiments. In comparison, mLANAF G418-resistant cell
outgrowth occurred in only 30 wells seeded at 1,000 cells/well,
2 wells seeded at 100 cells/well, and 0 wells seeded at 10 cells/
well. The higher rate of G418-resistant cell outgrowth for cells
transfected with mTR-containing DNA than that for cells in the
absence of mTR DNA provided evidence for a higher rate of inte-
gration of mTR-containing plasmids into the host genome. Since
there was no increase in the G418 outgrowth rate with mLANA
and mTRs expressed in cis, results were consistent with either a
lack of episome persistence or an efficiency of episome persistence
that was no higher than that of integration.
G418-resistant cell lines were expanded and assessed for the
presence of episomes by Gardella gel analysis at 47 days postselec-
tion. As expected, neither m4TR (Fig. 5A, lanes 5 to 7), which lacks
mLANA, nor mLANAF (Fig. 5A, lanes 22 to 24), which lacks mTR
elements, had episomes. In contrast, mLANAF-m4TR persisted as
episomal DNA in 10 (Fig. 5A, lanes 8 to 10, 12 to 16, 19, and 21) of
14 lanes. Notably, most of the episomal signal migrated much
more slowly than the covalently closed circular mLANAF-m4TR
plasmid (Fig. 5A, lane 3, bottom band) and even slower than ep-
isomal MHV68 from infected S11 cells (Fig. 5A, lane 1, upper
band), consistent with selection for recombination into very large
episomes. In two experiments, mLANAF-m4TR had episomes in
19 of 45 (42%) G418-resistant cell lines. Furthermore, in two
additional experiments, mLANA-m4TR, which is similar to
mLANAF-m4TR except that mLANA lacks a C-terminal epitope
tag, episomes were present in 18 of 42 (43%) G418-resistant cell
lines (data not shown). Since mLANAF-m4TR persisted as epi-
somal DNA with an efficiency similar to that of mLANA-m4TR,
the C-terminal FLAG tag did not adversely affect mLANA func-
tion.
To assess the long-term stability of the episomes, selected
G418-resistant cell lines were again assayed by Gardella gel analy-
sis after 173 days of selection. All five cell lines (Fig. 5B, lanes 8 to
14) continued to stably maintain episomal mLANAF-m4TR
DNA. Therefore, episomes were stable for at least 6 months in
continuous culture.
mLANA expression was assessed in these G418-resistant cell
lines. As expected, no signal was detected in m4TR (Fig. 5C, lanes
1, 13, and 14)-transfected cell lines, since this plasmid lacks
mLANA. mLANAF expression was detected in only one (Fig. 5C,
lane 21) of three (Fig. 5C, lanes 11, 12, 20, and 21) mLANAF-
transfected, G418-resistant cell lines and was expressed at a rela-
tively low level. In contrast, mLANAF expression was detected in
all mLANAF-m4TR cell lines (Fig. 5C, lanes 2 to 10 and 15 to 18)
and was robust in all lines except for one that contained very low
levels of episomes (Fig. 5A, lane 21). For this cell line, mLANAF
could be detected only on longer exposure (Fig. 5C, middle panel,
lane 19). It is interesting that robust mLANAF expression (Fig. 5C,
lanes 5, 15, 16, and 18) was present even in cell lines that lacked
episomes (Fig. 5A, lanes 11, 17, 18, and 20) when the plasmid was
integrated.
We observed that A20 cells expressing mLANA proliferated at
a lower rate than that of cells that did not express mLANA, sug-
gesting that mLANA may exert growth-inhibitory effects. There-
fore, it is possible that when cell outgrowth is robust in nearly all
wells, such as after plating 1,000 cells/well after transfection of
mTR-containing plasmids, cells with integrated plasmid and lack-
ing mLANA expression may overgrow those cells which contain
episomes and express mLANA. However, in these experiments,
Gardella gel analyses were generally done from plates seeded with
100 cells/well that had low levels of G418-resistant outgrowth, in
which outgrowth is expected to be nearly clonal.
The presence of two or eight mTR elements instead of four
mTR elements in ciswith mLANA was also assessed with regard to
episome maintenance. In three experiments, mLANA-m2TR
(without an epitope tag) had episomes in 14 of 32 (44%) G418-
resistant cell lines, while in two experiments, mLANAF-2mTR
(containing a FLAG tag) had episomes in 5 of 18 (28%) cell lines
(data not shown). These rates of episome persistence were very
similar to those with four mTRs (42% for mLANAF-m4TR and
43% for mLANA-m4TR). mLANA-m8TRrev-transfected, G418-
resistant cell lines contained episomes in only 3 (Fig. 5D, lanes 7, 8,
and 14) of 12 (Fig. 5D, lanes 3 to 14) cell lines. In two experiments,
mLANA-m8TRrev had episomes in 3 of 16 (19%) G418-resistant
cell lines, and the signal was very weak in two of the lanes (Fig. 5D,
lanes 7 and 14). Two additional experiments assessing mLANAF-
m8TRrev (containing an mLANA FLAG epitope tag) had epi-
somes in 2 of 21 (10%) G418-resistant cell lines. Therefore,
mLANA-m8TRrev and mLANAF-m8TRrev had lower efficien-
cies of episome persistence than vectors containing two or four
copies of mTR. This lower efficiency was likely due to lower
FIG 4 mLANA levels after transfection of different expression vectors. A20
cells were transfected with the indicated plasmids and harvested for immuno-
blotting 72 h later, except for the sample in lane 12. The gel shows A20 cells
(lanes 1 and 13) and A20 cells transfected with m4TR (lane 2), CmLANAF-
m4TR (lanes 3 and 14), CmLANAF-m2TR (lane 4), CmLANAF (lane 5),
m8TR (lane 6), mLANAF-m8TRrev (lane 7), mLANAF-m4TR (lane 8),
mLANAF-m2TR (lane 9), mLANAF (lane 10), mLANAF-m8TR (lane 11), or
CmLANAF-m8TRrev (lane 15). Lane 12 contains mLANA-m4TR cl.a, which
is the G418-resistant cell line containing episomes shown in Fig. 5A, lane 8. The
bottom panel shows a tubulin immunoblot for the same cells. A total of 0.25
106 cells was loaded in each lane. The middle panel shows a shorter exposure
(10 s) of lanes 8 to 12 than the 10-min exposure for these lanes in the top panel.
The top right panel shows a 20-min exposure. This figure is representative of at
least two experiments.
Habison et al.
11870 jvi.asm.org Journal of Virology
mLANA expression from this construct, which has the mTRs re-
versed from their native orientation relative to mLANA (Fig. 4,
lane 7). In the absence of mLANA (Fig. 5D, lanes 16 to 23), no
episomes were observed. Therefore, episome persistence occurred
only when mLANA and mTRs were together in cis, and episome
persistence was more efficient at higher mLANA expression levels.
mLANA maintains mTR episomes in MEF cells. Since
mLANA in cis with mTRs persisted as episomal DNA in A20 B
lymphoma cells, we assessed if mLANA could also maintain epi-
somes in another cell type. Therefore, MEF cells were trans-
fected with mLANA, mLANAF, m4TR, m8TR, mLANA-m2TR,
mLANA-m4TR, mLANA-8TRrev, or mLANAF-m4TR and
placed under G418 selection. G418-resistant colonies were ex-
panded independently and assessed by Gardella gel analysis for the
presence of episomes. As expected, the mLANA (Fig. 6B, lanes 5 to
8), mLANAF (Fig. 6C, lanes 12 and 13), m4TR (Fig. 6C, lanes 6
and 7), and m8TR (Fig. 6A, lanes 18 to 24, and B, lane 13) cell lines
did not contain episomes. mLANA-m2TR contained episomes in
4 of 5 lanes (80%) (Fig. 6B, lanes 14, 15, 17, and 18), mLANA-
m4TR had episomes in 8 of 12 lanes (67%) (Fig. 6A, lanes 12 to 14,
FIG 5 Native promoter-driven mLANA in cis with mTR elements persists in episomal form with increased efficiency. A20 cells were transfected with plasmids
containing native promoter-driven mLANA with mTR elements or with mTR DNA. Seventy-two hours later, cells were seeded into microtiter plates at 1,000,
100, or 10 cells/well and placed under G418 selection. A total of 2 106 to 3 106 cells was loaded per lane for Gardella gels. (A) Gardella gel containing S11 cells
(lane 1), naked m4TR plasmid DNA (lane 2), naked mLANAF-m4TR plasmid DNA (lane 3), naked mLANAF plasmid DNA (lane 4), G418-resistant, m4TR-
transfected A20 cells (lanes 5 to 7), G418-resistant, mLANAF-m4TR-transfected A20 cells (lanes 8 to 21), and G418-resistant, mLANAF-transfected A20 cells
(lanes 22 to 24). G418-resistant cell lines were taken from plates seeded with 1,000 cells per well (lanes 22 to 24), 100 cells per well (lanes 5 to 11 and 17 to 20),
or 10 cells per well (lanes 12 to 16 and 21). (B) Gardella gel containing S11 cells (lane 1), A20 cells (lane 2), naked m4TR DNA (lane 3), naked mLANAF-m4TR
DNA (lane 4), naked mLANAF DNA (lane 5), and A20 cells after 173 days of G418 selection (lanes 6 to 16). Letters above the lanes correspond to the same letters
in panel A. (C) Immunoblot of mLANA G418-resistant cell lines from panel A. Lane letters correspond to the same letters as in panel A. Lanes 11 and 20 contain
cells from the same G418-resistant “b” cell line. A total of 0.25 106 cells was loaded per lane. The middle panel shows a longer exposure for lanes 18 to 22. The
bottom panel shows a tubulin immunoblot. (D) Gardella gel containing naked mLANA-m8TRrev DNA (lane 1), naked m8TR DNA (lane 2), G418-resistant,
mLANA-m8TRrev-transfected A20 cells (lanes 3 to 14), A20 cells (lane 15), and G418-resistant, m8TR-transfected A20 cells (lanes 16 to 23). G418-resistant cell
lines were taken from plates seeded with 1,000 cells per well (lanes 3 to 21) or 100 cells per well (lanes 22 and 23). The figure is representative of at least two
experiments. Numbers of days of G418 selection are indicated below the panels. The faster-migrating bands in S11 lanes are linear MHV68 genomic DNA from
cells undergoing lytic infection, and the slower-migrating band is episomal MHV68. The fastest-migrating bands in naked DNA lanes are circular covalently
closed DNA. Blots in panels A, B, and D were probed with 32P-radiolabeled m8TR DNA. Vertical lines in panel D indicate episomal DNA.
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16, and 17, and data not shown), mLANA-m8TRrev contained
episomes in 1 (Fig. 6B, lane 10) of 11 lanes (9%) (Fig. 6A, lanes 4 to
10, and B, lanes 9 to 12), and mLANAF-m4TR had episomes in 3
of 4 lanes (75%) (Fig. 6C, lanes 8, 9, and 11). Western blot analysis
of mLANAF protein expression demonstrated that the mLANAF-
m4TR-transfected cell line lacking episomes (Fig. 6C, lane 10)
expressed mLANAF at a robust level that was only slightly lower
than that of cells containing episomes (Fig. 6C, lanes 8, 9, and 11),
while cells transfected with mLANAF without mTRs had signifi-
cantly reduced or no mLANAF expression (data not shown).
These expression patterns were similar to those in A20 cells (Fig.
5C). The lower rate of episome persistence for mLANA-m8TRrev
was similar to that in A20 cells and was likely due to lower mLANA
protein expression. As observed in A20 cells, MEF cells expressing
mLANA proliferated at a lower rate than that of MEF cells not
expressing mLANA. Therefore, mLANA acts on mTR DNA to
mediate episome persistence in MEF cells.
Native genomic orientation of eight mTR elements in cis
with mLANA increases episome persistence efficiency. We in-
vestigated whether the native genomic orientation of eight mTRs
in cis with mLANA would affect the efficiency of episome main-
tenance, since mLANA-m8TRrev, in which the mTR orientation
is reversed, was less efficient than mLANA in cis with only two or
four mTRs in both A20 and MEF cells. Therefore, we generated
mLANAF-m8TR, which contains eight mTR elements in native
genomic orientation upstream of mLANA (Fig. 1C). Transfection
of mLANAF-m8TR (Fig. 4, lane 11) into A20 cells demonstrated
substantially more mLANA expression than that of mLANAF-
m8TRrev (Fig. 4, lane 7), and the level was somewhat higher than
that of mLANAF-m4TR (Fig. 4, middle panel, lane 8). The expres-
sion level of mLANAF-m8TR was only slightly lower than the
expression level of mLANA in a G418-resistant cell line maintain-
ing mLANAF-m4TR episomes (Fig. 4, middle panel, lane 12).
We assessed the ability of mLANAF-m8TR to persist as an
episome. mLANAF-m8TR, m8TR, and mLANAF were each
transfected into A20 cells, plated in microtiter plates, and selected
for G418 resistance. As expected, m8TR (Fig. 7A, lanes 6 and 7)
and mLANAF (Fig. 7A, lanes 22 and 23) did not have episomes. In
contrast, mLANAF-m8TR had episomal DNA in 9 (Fig. 7A, lanes
9 to 11, 14 to 16, 18 to 19, and 21) of 15 (Fig. 7A, lanes 8 to 21) cell
lines. In two experiments, mLANAF-8TR had episomes in 13 of 18
(72%) cell lines. This episome maintenance efficiency was sub-
stantially higher than that of mLANAF-m8TRrev (10%) or
mLANA-m8TRrev (19%) and was even higher than that of
mLANA in native orientation with two or four mTRs in A20 cells
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FIG 6 mLANA in cis with mTR elements persists in episomal form in MEF
cells. MEF cells were transfected with plasmids containing native promoter-
driven mLANA in cis with mTR elements or mTR elements alone. Forty-eight
hours later, cells were trypsinized, reseeded into 15-cm dishes, and placed
under G418 selection. (A) Gardella gel containing naked mLANA-m4TR DNA
(lane 1), naked m8TR DNA (lane 2), naked mLANA-m8TRrev DNA (lane 3),
G418-resistant, mLANA-m8TRrev-transfected MEF cells (lanes 4 to 10), G418-
resistant, mLANA-m4TR-transfected MEF cells (lanes 11 to 16), and G418-resis-
tant, m8TR-transfected MEF cells (lanes 19 to 24). (B) Gardella gel containing
naked mLANA DNA (lane 1), naked mLANA-m8TRrev DNA (lane 2), naked
mLANA-m2TR DNA (lane 3), MEF cells (lanes 4 and 19), G418-resistant,
mLANA-transfected MEF cells (lanes 5 to 8), G418-resistant, mLANA-m8TRrev-
transfected MEF cells (lanes 9 to 12), G418-resistant, m8TR-transfected MEF cells
(lane 13), and mLANA-m2TR-transfected MEF cells (lanes 14 to 18). (C) Gardella
gel containing S11 cells (lane 1), MEF cells (lane 2), naked m4TR DNA (lane 3),
naked mLANAF-m4TR DNA (lane 6), naked mLANAF DNA (lane 5), G418-
resistant, m4TR-transfected MEF cells (lanes 6 and 7), G418-resistant, mLANAF-
m4TR-transfected MEF cells (lanes 8 to 11), and G418-resistant, mLANAF-trans-
fected MEF cells (lanes 12 and 13). A total of1 106 MEF cells was loaded per
lane in Gardella gels. Numbers of days of G418 selection are indicated at the bot-
tom of panels. Blots were probed with 32P-radiolabeled m8TR DNA.
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(Fig. 1C). Therefore, native orientation of the eight mTR elements
substantially increased both mLANA expression and episome per-
sistence.
Immunoblot analysis demonstrated that mLANA was ex-
pressed at robust levels in all mLANAF-m8TR cell lines (Fig. 7B,
lanes 3 to 9 and 13 to 19). Even cell lines lacking episomes (Fig. 7B,
lanes 3, 7 to 8, 15, and 18), which therefore contained integrated
plasmid, expressed mLANA, similar to the findings with inte-
grated mLANAF-m4TR (Fig. 5C). Notably, cell lines transfected
with mLANAF, which contains the native mLANA promoter im-
mediately upstream of mLANA but no mTR elements, did not
express mLANA (Fig. 7B, lanes 10 and 20).
mLANA redistributes and concentrates to dots along mitotic
chromosomes in the presence of episomes. mLANA was detected
in MEF cells (Fig. 8) containing mLANAF-m4TR episomes (cell
line from Fig. 6C, lane 11) and in MEF cells deficient in episomes,
for which no episomes were detected on Gardella gel analysis (cell
line from Fig. 6C, lane 10). In episome-deficient cells (Fig. 8A to
D), mLANAF (green) was distributed broadly throughout the nu-
cleus (red) in interphase and over mitotic chromosomes (red)
(overlay of green and red generates yellow). In contrast, in the
presence of episomes (Fig. 8E to H), mLANAF (green) was con-
centrated to dots both in interphase and along mitotic chromo-
somes (red) (overlay of green and red generates yellow). There-
fore, in the presence of episomes, mLANA relocalized to dots
along mitotic chromosomes.
DISCUSSION
This work demonstrates that mLANA acts on the mTR elements
to mediate episome persistence. DNA containing mTR elements
persisted as episomes in latently MHV68-infected S11 cells, indi-
cating that the cis-acting element for episome persistence is lo-
cated in the mTRs. Furthermore, plasmids containing mLANA
expression cassettes and mTR elements in cis were capable of per-
sisting as episomes in both murine A20 B lymphoma cells and
MEF cells. In contrast, neither mTR elements nor mLANA alone
ever persisted as episomal DNA, consistent with a requirement for
both factors for episomal maintenance.
These findings follow earlier work which suggested an episome
maintenance role for mLANA. LANA is the episome maintenance
protein for KSHV and acts on KSHV TR DNA to maintain epi-
somes (3–5, 14). Similarly, HVS LANA binds to and acts on HVS
TR elements to mediate episome persistence (10, 11, 13, 30, 31, 63,
68). mLANA is the MHV68 positional homolog for both KSHV
and HVS LANA proteins and also shares sequence homology with
these proteins. Furthermore, studies which abolished mLANA ex-
pression by introduction of specific mutations demonstrated that
mLANA is critical for MHV68’s ability to establish latent infection
in mice (25, 48). Notably, later work showed that MHV68 lacking
mLANA expression could persist at low levels in murine spleno-
cytes, especially after intraperitoneal injection. However, MHV68
was unable to reactivate from splenocytes, and no episomal DNA
could be detected in the latently infected cells. This finding was
consistent with either integration into host chromosomes or
FIG 7 mLANA in cis with mTR elements in native orientation enhances epi-
some persistence. (A) Gardella gel containing S11 cells (lane 1), A20 cells (lane
2), naked m8TR DNA (lane 3), naked mLANA F-m8TR DNA (lane 4),
mLANAF (lane 5), G418-resistant, m8TR-transfected A20 cells (lanes 6 and 7),
G418-resistant, mLANAF-m8TR-transfected A20 cells (lanes 8 to 21), and
G418-resistant, mLANAF-transfected A20 cells (lanes 22 and 23). G418-resis-
tant cell lines were taken from plates seeded with 1,000 cells per well (lanes 22
and 23), 100 cells per well (lanes 6 to 18), or 10 cells per well (lanes 19 to 21). A
total of 1.5  106 cells was loaded per lane. The number of days of G418
selection is shown at the bottom. The blot was probed with 32P-radiolabeled
m8TR DNA. (B) Immunoblot of mLANAF and tubulin for cells in panel A.
Letters above lanes correspond to the same letters in panel A.
FIG 8 mLANA concentrates to dots along mitotic chromosomes in the pres-
ence of episomes but is broadly distributed along chromosomes in episome-
deficient cells. mLANAF was detected in MEF cells deficient for episomes (A to
D; cells from Fig. 6C, lane 10) or in MEF cells containing mLANAF-m4TR
episomes (E to H; cells from Fig. 6C, lane 11). Cells were in interphase (A, B, E,
and F) or metaphase (C, D, G, and H). Overlay of green (mLANAF) with red
(DNA) generates yellow. Panels C and D contain two mitotic cells. The two
paired dots in panels C and D are likely due to the presence of rare episomes
that were not detected by the Gardella gel. Brightness and contrast were uni-
formly adjusted for some panels from the same field by use of Adobe Photo-
shop. Magnification,630.
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maintenance of DNA in a linear state, therefore indicating a role
for mLANA in the formation or maintenance of episomes (50).
Initial experiments transfecting mTR plasmids into S11 cells
were consistent with the mTRs acting as the cis-acting element for
episome persistence but were complicated by the finding of vector
integration into MHV68 episomal genomes in some G418-resis-
tant cell lines. Furthermore, some of the transfected mTR plas-
mids that persisted as episomes were also integrated into MHV68
genomes. The mTR plasmids contain homologous mTR se-
quences, which may have facilitated recombination of the trans-
fected plasmid into the mTR elements of MHV68 genomes. How-
ever, the integration of nonhomologous pRepCK vector DNA
into episomal viral episomes was highly unexpected. S11 cells con-
tain40 MHV68 genomes per cell (61). The MHV68 genome is
comprised of 120 kb of unique sequence, plus an unknown
number of mTR elements (64). Assuming an mTR copy number
of 40, similar to that in KSHV, the total MHV68 genome con-
sists of170 kb. Therefore, there are7 106 bp of MHV68 per
S11 cell, compared with 2.5 109 bp of cell DNA (66), so MHV68
accounts for only0.3% of the total DNA present in the cell. The
finding that 3 of 6 (50%) G418-resistant cell lines had vector in-
tegrated into MHV68 episomes indicates a150-fold higher rate
of integration than expected if integration were completely sto-
chastic. It is possible that integration occurred in cells undergoing
lytic replication, which contained increased levels of MHV68 DNA
and therefore increased the possibility of integration. Virions released
from these dying cells may then have superinfected latently infected
cells to form episomes. Although we do not know if the site of inte-
gration in MHV68 is the same for each G418-resistant line, it is pos-
sible that MHV68 may contain a certain sequence, perhaps the mTR
elements, that is highly prone to recombination.
Gardella gel analyses demonstrated that episomes with
mLANA and mTRs migrated much more slowly than the input
plasmids (Fig. 2, 3, 5, 6, and 7), consistent with recombination
events leading to substantial size increases. In fact, much of the
episomal signal migrated slower than the 170-kb MHV68 epi-
somes in S11 cells (Fig. 5 to 7). We previously observed similar
increases in episome size in KSHV LANA episome maintenance,
due to TR duplication and generation of input plasmids into mul-
timers (4, 18). It is likely that there is strong selection for recom-
bination events leading to increased numbers of mTR elements
and/or an increased copy number of the mLANA expression cas-
sette. If MHV68 contains40 TR elements (similar to KSHV) and
therefore represents an optimal number for episome mainte-
nance, recombination events leading to larger numbers of mTRs
(up to40 copies) may occur.
Although MHV68 ORF74 and the C-terminal portion of
ORF75C are included in the upstream sequence of the mLANA
constructs containing the native promoter sequence (Fig. 1B), it is
highly unlikely that either exerts a role in episome persistence.
Most importantly, episome persistence occurred in the absence of
ORF74 and truncated ORF75C with plasmids containing CMV-
driven mLANA and mTRs (Fig. 3). Though episome maintenance
efficiency was lower with CMV-driven mLANA, this finding cor-
related with a lower level of mLANA expression from these con-
structs. In addition, both mLANAF-m8TRrev (Fig. 5 and 6) and
mLANAF-8TR (Fig. 7) contain the same mLANA upstream se-
quence yet had substantially different episome maintenance effi-
ciencies (Fig. 1C). The difference between these two plasmids is
only the orientation of the mTR elements in relation to the
mLANA cassette, which resulted in much higher mLANA expres-
sion for mLANAF-8TR, with a concomitant increase in episome
maintenance efficiency. Furthermore, ORF75C is severely trun-
cated, while ORF74 is a plasma membrane protein homologous to
KSHV ORF74, which is a G protein-coupled receptor (65), and its
plasma membrane location is not compatible with episome main-
tenance function.
The presence of the mTR elements in genomic orientation sub-
stantially enhanced mLANA expression (Fig. 4, 5, and 7). At least
three promoters for mLANA have been described (Fig. 1B). Two
are located within the terminal repeat elements, with one either
completely (12) or partially (2) contained in the left half of the
mTR and one in the right half of the mTR (2, 12). A third pro-
moter is located just proximal to mLANA (12). In addition, the
mTR element has enhancer activity for the promoter in the left
half of the mTR (2), while the left end of the unique sequence of
the MHV68 genome (which was not present in the constructs used
here) has enhancer activity for the promoter in the right half of the
mTR (12). Since the addition of the mTR elements in native ori-
entation to mLANA substantially enhanced its expression (Fig. 4),
it is likely that an mTR promoter was driving the enhanced
mLANA expression. It is also possible that the mTR provided
enhancer activity to the promoter immediately upstream of
mLANA, although the orientation dependence of the mTR ele-
ments, in which expression was enhanced only in the native, not
reverse, genomic orientation relative to mLANA in the constructs
containing eight mTR elements, makes this scenario less likely.
When expressed from MHV68, mLANA transcripts contain up to
three 5=-untranslated exons, including one at the right end of the
unique MHV68 genome and up to two different exons from
within the mTR elements (2, 12, 34) (Fig. 1B). Since the unique
sequence at the right end of the MHV68 genome is absent in the
constructs used here, this exon would be omitted in our experi-
ments when transcription occurs from the mTRs. We observed
increased mLANA expression with a higher mTR copy number
(Fig. 4), and this could be consistent with multiple active mTR
promoters being active and/or increased numbers of mTR en-
hancer elements acting on the mTR promoter(s). Notably, the
splice acceptor site just upstream of the mLANA ORF is present in
the constructs with the native upstream mLANA sequence but
absent in the CMV promoter constructs, so splicing to this site can
occur only in those constructs where the native sequence is pres-
ent. It is possible that the increased expression of mLANA from
the CMV promoter in the presence of four upstream mTR ele-
ments (Fig. 4) could be due to mTR enhancer activity or a cryptic
splice acceptor site resulting in the mTR promoter driving expres-
sion. The generally low expression level from the CMV promoter
observed here could possibly be improved with a stronger Kozak
consensus sequence.
Transcription of mLANA has several notable differences from
that of KSHV LANA. In contrast to the mLANA promoters, the
KSHV LANA promoter is located only immediately upstream of
the LANA ORF, and there are not additional promoters in the
KSHV TR elements. Of note, the promoter for the KSHV K1 gene
does extend into the TR, but this is located in the opposite orien-
tation from that of LANA to drive K1 expression at the extreme
left end of the KSHV genome (9, 62). In addition, the KSHV
LANA transcript is polycistronic and includes two additional
ORFs, those of v-cyclin and v-FLIP, while the MHV68 transcript
contains only the mLANA ORF (19, 55, 60). Another distinguish-
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ing feature between KSHV and MHV68 is that the LANA pro-
moter is activated by LANA (35, 52), while mLANA modestly
downregulates the mLANA promoters (12). Also, KSHV ORF50,
the lytic switch protein, activates the LANA promoter (43, 47),
while mORF50 represses the promoter immediately upstream of
mLANA and has little effect on the mTR promoters (12).
In comparison with KSHV LANA, the efficiency of mLANA
episome persistence in these experiments appears to be relatively
low. The highest efficiency of episome persistence in A20 cells
occurred with mLANAF-8TR, for which 72% of G418-resistant
cell lines contained episomes, and this efficiency was lower when
plasmids contained only four or two mTR elements. Episome
maintenance efficiency was somewhat higher in MEF cells than in
A20 cells (up to 80% of mLANA-m2TR G418-resistant cell lines
had episomes), although this finding was based on assessment of
relatively few cell lines. Notably, the absence of episomes was not
always due to a loss of mLANA expression, since mLANA contin-
ued to be expressed even in the absence of detectable episomes
(Fig. 5 and 7). In contrast, in similar experiments with KSHV
LANA constructs containing a LANA expression cassette with
eight TR elements in cis, 100% of G418-resistant cell lines con-
tained episomes (our unpublished data). It is possible that more
mTR elements may be present in the MHV68 genome than the
40 elements in KSHV, and therefore more mTR elements may
be necessary for efficient episome persistence. KSHV LANA is a
larger protein than MHV68 LANA and may have evolved to be
more efficient in its episome persistence.
This work demonstrates that mLANA is nuclear and associates
with mitotic chromosomes (Fig. 8). The pattern of distribution is
very similar to that of KSHV LANA. In the absence of episomes,
LANA distributes broadly throughout interphase nuclei and over
mitotic chromosomes. However, when KSHV episomes are pres-
ent, LANA is concentrated at dots at the sites of KSHV DNA both
in interphase and along mitotic chromosomes (3, 5, 6, 14, 36, 38,
42, 51). mLANA was broadly distributed throughout the nucleus
and over mitotic chromosomes in episome-deficient cells but was
concentrated at dots in interphase nuclei and along mitotic chro-
mosomes in episome-containing cells. It is likely that mLANA
concentrates at sites of MHV68 episomes. This finding supports
the hypothesis that mLANA directly tethers MHV68 episomes to
mitotic chromosomes to allow for efficient segregation to daugh-
ter nuclei, similar to the tethering mechanism of KSHV LANA (3,
14). This mechanism of bridging episomes to chromosomes has
also been proposed for HVS LANA (11, 13, 63). It is likely that
mLANA attaches to episomes through direct binding of mTR
DNA, similar to KSHV and HVS LANAs (4, 13, 15, 21, 28, 63, 68).
In summary, this work demonstrates that mLANA acts on
MHV68 mTR DNA to mediate episome persistence. These results
suggest that mLANA tethers mTR DNA to mitotic chromosomes
to efficiently segregate MHV68 DNA into progeny nuclei. Future
work is necessary to understand the molecular mechanisms un-
derlying this process and to better understand the similarities and
differences between KSHV and MHV68 LANA functions.
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